{"id":"W2207823877","doi":"10.3111/13696998.2015.1131705","title":"Real-world dosing and drug costs with everolimus or axitinib as second targeted therapies for advanced renal cell carcinoma: a retrospective chart review in the US","year":2015,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Comprehensive Cancer Network; Canadian Centre for Applied Research in Cancer Control","keywords":"Axitinib; Everolimus; Medicine; Sunitinib; Hazard ratio; Internal medicine; Renal cell carcinoma; Pazopanib; Oncology; Sorafenib; Retrospective cohort study; Dosing; Discontinuation; Confidence interval; Hepatocellular carcinoma","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002231928,0.0002286731,0.0008593616,0.0001444164,0.00005078765,0.00003176047,0.000203056,0.00008275562,0.0001554362],"category_scores_gemma":[0.0003209428,0.0001221952,0.0001296294,0.0001437961,0.0001412288,0.0001629246,0.00003193492,0.0005299489,0.000003122222],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007096101,"about_ca_system_score_gemma":0.001099717,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008884254,"about_ca_topic_score_gemma":0.0007292544,"domain_scores_codex":[0.9981198,0.0001378991,0.0007647077,0.0002400404,0.0004505444,0.0002870176],"domain_scores_gemma":[0.9981249,0.0003773176,0.0005905625,0.0002266164,0.0002189974,0.0004616269],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1331439,0.007084365,0.4768618,0.01236604,0.004187103,0.02243844,0.05249672,0.0001773998,0.001820786,0.003754621,0.1631884,0.1224804],"study_design_scores_gemma":[0.1736926,0.0430742,0.525924,0.02024672,0.003552776,0.02497542,0.01250312,0.001255708,0.01309642,0.003817892,0.1756451,0.002216028],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9737985,0.01240257,0.00001103115,0.01088114,0.0001410361,0.0008376799,0.00001235154,0.00000572616,0.001909947],"genre_scores_gemma":[0.9862157,0.008591291,0.0009939955,0.003399654,0.0003685482,0.00003501349,0.00001096537,0.00003220383,0.0003527007],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1202644,"threshold_uncertainty_score":0.4982975,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02393487756643908,"score_gpt":0.2883542912529376,"score_spread":0.2644194136864985,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}